{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:06:42Z","timestamp":1784696802523,"version":"3.55.0"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>The efficacy of T-cell based immunotherapies relies on the presentation of tumor-specific antigens via the major histocompatibility complex (MHC) class I pathway. In head and neck squamous cell carcinoma (HNSCC), most patients display primary or acquired resistance to these therapies, many failing to derive long term clinical benefits. While the presence of antigen processing machinery (APM) deficits is well documented, the relative contribution of transcriptional, epigenetic, and post translational mechanisms to APM regulation remains a growing area of investigation. This review provides a synthesis of the structure of the APM and the driving factors, ranging from genetic mutations to regulatory networks, that may contribute to its deficit in HNSCC. We explain how oncogenic signaling and environmental stressors may take part in the degradation and epigenetic silencing of the MHC-I pathway, limiting the predictive utility of biomarkers like PD-L1. By evaluating the impact of tumor heterogeneity and demographic disparities on APM integrity, we look at several therapeutic strategies to restore tumor visibility. Ultimately, these evasion strategies provide a framework for developing personalized, adaptive regimens to overcome immunotherapy resistance and improve clinical outcomes for HNSCC patients.<\/jats:p>","DOI":"10.3389\/fonc.2026.1907861","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:46:10Z","timestamp":1784695570000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Antigen processing machinery deficits in head and neck cancers: mechanisms of immune evasion and strategies for therapeutic restoration"],"prefix":"10.3389","volume":"16","author":[{"given":"Poorvi","family":"Iyer","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, University of Georgia","place":["Athens, GA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan L. C.","family":"Kinney","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology \u2013 Head and Neck Surgery, Emory University","place":["Atlanta, GA, United States"]},{"name":"Winship Cancer Institute, Emory University","place":["Atlanta, GA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna","family":"Brammer","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology \u2013 Head and Neck Surgery, Emory University","place":["Atlanta, GA, United States"]},{"name":"Emory University School of Medicine","place":["Atlanta, GA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell Y.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology \u2013 Head and Neck Surgery, Stanford University","place":["Palo Alto, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Walker","family":"Rosenthal","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine","place":["Atlanta, GA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole C.","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology \u2013 Head and Neck Surgery, Emory University","place":["Atlanta, GA, United States"]},{"name":"Winship Cancer Institute, Emory University","place":["Atlanta, GA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/hed.22015","article-title":"Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer\u2014systematic review and meta-analysis of trends by time and region","volume":"35","author":"Mehanna","year":"2013","journal-title":"Head Neck"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet Lond Engl"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.1524","article-title":"Pembrolizumab for platinum- and cetuximab-refractory head and neck cancer: results from a single-arm, phase II study","volume":"35","author":"Bauml","year":"2017","journal-title":"J Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.1478","article-title":"Antitumor activity of pembrolizumab in biomarker-unselected patients with recurrent and\/or metastatic head and neck squamous cell carcinoma: results from the phase Ib KEYNOTE-012 expansion cohort","volume":"34","author":"Chow","year":"2016","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-1860","article-title":"Immune escape mechanisms as a guide for cancer immunotherapy","volume":"21","author":"Beatty","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-04737-8","article-title":"Cancer immune escape: the role of antigen presentation machinery","volume":"149","author":"Kallingal","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.1509","article-title":"Immunology and immunotherapy of head and neck cancer","volume":"33","author":"Ferris","year":"2015","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2146","article-title":"Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome","volume":"11","author":"Meissner","year":"2005","journal-title":"Clin Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-0488","article-title":"HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker","volume":"66","author":"Ogino","year":"2006","journal-title":"Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2023.106309","article-title":"Tumor cell HLA class I expression and pathologic response following neoadjuvant immunotherapy for newly diagnosed head and neck cancer","volume":"138","author":"Robbins","year":"2023","journal-title":"Oral Oncol"},{"key":"B13","first-page":"393","article-title":"Further experimental studies on the inheritance of susceptibility to a transplantable tumor, carcinoma (J. W. A.) of the Japanese waltzing mouse","volume":"33","author":"Little","year":"1916","journal-title":"J Med Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF02986826","article-title":"Methods for the study of histocompatibility genes","volume":"49","author":"Snell","year":"1948","journal-title":"J Genet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/248701a0","article-title":"Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system","volume":"248","author":"Zinkernagel","year":"1974","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(86)90019-x","article-title":"The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides","volume":"44","author":"Townsend","year":"1986","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.8342042","article-title":"Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter","volume":"261","author":"Neefjes","year":"1993","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(94)90462-6","article-title":"Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules","volume":"78","author":"Rock","year":"1994","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5330.1306","article-title":"A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes","volume":"277","author":"Ortmann","year":"1997","journal-title":"Science"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.65.070196.004101","article-title":"Structure and functions of the 20S and 26S proteasomes","volume":"65","author":"Coux","year":"1996","journal-title":"Annu Rev Biochem"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1126\/science.7725097","article-title":"Crystal structure of the 20 S proteasome from the archaeon T. acidophilum at 3.4 \u00c5 resolution","volume":"268","author":"L\u00f6we","year":"1995","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.17.1.739","article-title":"Degradation of cell proteins and the generation of MHC class I-presented peptides","volume":"17","author":"Rock","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1996.00404.x","article-title":"Effects of major\u2010histocompatibility\u2010complex\u2010encoded subunits on the peptidase and proteolytic activities of human 20S proteasomes: cleavage of proteins and antigenic peptides","volume":"235","author":"Ehring","year":"1996","journal-title":"Eur J Biochem"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.6.3363","article-title":"The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes","volume":"274","author":"Kisselev","year":"1999","journal-title":"J Biol Chem"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/384134a0","article-title":"Structure of the complex between human T-cell receptor, viral peptide and HLA-A2","volume":"384","author":"Garboczi","year":"1996","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/355641a0","article-title":"Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex","volume":"355","author":"Kelly","year":"1992","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.157.12.5467","article-title":"Multiple regions of the transporter associated with antigen processing (TAP) contribute to its peptide binding site","volume":"157","author":"Nijenhuis","year":"1996","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.19.9130","article-title":"Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner","volume":"90","author":"Androlewicz","year":"1993","journal-title":"Proc Natl Acad Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(01)00073-2","article-title":"Distinct functional properties of the TAP subunits coordinate the nucleotide-dependent transport cycle","volume":"11","author":"Alberts","year":"2001","journal-title":"Curr Biol"},{"key":"B30","article-title":"Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer","volume":"55","author":"Kaklamanis","year":"1995","journal-title":"Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/353321a0","article-title":"The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation","volume":"353","author":"Madden","year":"1991","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1126\/science.2124002","article-title":"The role of \u03b22 -microglobulin in peptide binding by class I molecules","volume":"250","author":"Vitiello","year":"1990","journal-title":"Science"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80487-2","article-title":"Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP","volume":"5","author":"Sadasivan","year":"1996","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.33.19638","article-title":"Calnexin influences folding of human class I histocompatibility proteins but not their assembly with \u03b22-microglobulin","volume":"270","author":"Tector","year":"1995","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(98)70278-7","article-title":"The thiol oxidoreductase ERp57 is a component of the MHC class I peptide-loading complex","volume":"8","author":"Hughes","year":"1998","journal-title":"Curr Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199906)29:06<1858::AID-IMMU1858>3.0.CO;2-C","article-title":"The N-terminal region of tapasin is required to stabilize the MHC class I loading complex","volume":"29","author":"Bangia","year":"1999","journal-title":"Eur J Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1074-7613(02)00263-7","article-title":"Disulfide bond isomerization and the assembly of MHC class I-peptide complexes","volume":"16","author":"Dick","year":"2002","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)00081-9","article-title":"Selective export of MHC class I molecules from the ER after their dissociation from TAP","volume":"13","author":"Spiliotis","year":"2000","journal-title":"Immunity"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1212454","article-title":"Outcome differences in HPV-driven head and neck squamous cell carcinoma attributable to altered human leukocyte antigen frequencies","volume":"13","author":"Wichmann","year":"2023","journal-title":"Front Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/discim\/kyac001","article-title":"Unconventional modes of peptide\u2013HLA-I presentation change the rules of TCR engagement","volume":"1","author":"Hopkins","year":"2022","journal-title":"Discov Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401689","article-title":"Uncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I molecule","volume":"193","author":"Rasmussen","year":"2014","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-01225-1","article-title":"TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers","volume":"27","author":"Nagarsheth","year":"2021","journal-title":"Nat Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2021.07.006","article-title":"HLA class I antigen processing machinery defects in antitumor immunity and immunotherapy","volume":"7","author":"Maggs","year":"2021","journal-title":"Trends Cancer"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e89829","DOI":"10.1172\/jci.insight.89829","article-title":"The head and neck cancer immune landscape and its immunotherapeutic implications","volume":"1","author":"Mandal","year":"2016","journal-title":"JCI Insight"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2310821121","article-title":"Targeted demethylation and activation of NLRC5 augment cancer immunogenicity through MHC class I","volume":"121","author":"Sun","year":"2024","journal-title":"Proc Natl Acad Sci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"5999","DOI":"10.1073\/pnas.1602069113","article-title":"NLRC5\/MHC class I transactivator is a target for immune evasion in cancer","volume":"113","author":"Yoshihama","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1158\/1078-0432.CCR-19-1351","article-title":"Targeting EZH2 enhances antigen presentation, antitumor immunity, and circumvents anti\u2013PD-1 resistance in head and neck cancer","volume":"26","author":"Zhou","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2750","article-title":"Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer","volume":"12","author":"Ferris","year":"2006","journal-title":"Clin Cancer Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-010-0961-7","article-title":"Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes","volume":"60","author":"Leibowitz","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03589-y","article-title":"Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53","volume":"73","author":"Kinney","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-19-0545","article-title":"Phosphoinositide 3-kinase signaling can modulate MHC class I and II expression","volume":"17","author":"Chandrasekaran","year":"2019","journal-title":"Mol Cancer Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112508","article-title":"Human papillomavirus E5 suppresses immunity via inhibition of the immunoproteasome and STING pathway","volume":"42","author":"Miyauchi","year":"2023","journal-title":"Cell Rep"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112303","article-title":"Saturated fatty acids dampen the immunogenicity of cancer by suppressing STING","volume":"42","author":"Heath","year":"2023","journal-title":"Cell Rep"},{"key":"B54","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1158\/1078-0432.CCR-12-1517","article-title":"SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells","volume":"19","author":"Leibowitz","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005088","article-title":"NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module","volume":"11","author":"Ludigs","year":"2015","journal-title":"PloS Genet"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103160","article-title":"NLRC5 cooperates with the RFX transcription factor complex to induce MHC class I gene expression","volume":"188","author":"Meissner","year":"2012","journal-title":"J Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1038\/ncomms3359","article-title":"p53 increases MHC class I expression by upregulating the endoplasmic reticulum aminopeptidase ERAP1","volume":"4","author":"Wang","year":"2013","journal-title":"Nat Commun"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203235","article-title":"p53 induces TAP1 and enhances the transport of MHC class I peptides","volume":"18","author":"Zhu","year":"1999","journal-title":"Oncogene"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","year":"2015","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01726-23","article-title":"The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer","volume":"98","author":"Khalil","year":"2024","journal-title":"J Virol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-23-0622","article-title":"Hypoxia-induced long noncoding RNA HIF1A- AS2 regulates stability of MHC class I protein in head and neck cancer","volume":"12","author":"Liao","year":"2024","journal-title":"Cancer Immunol Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/lary.30761","article-title":"Loss of human leukocyte antigen and immune escape in head and neck cancer","volume":"134","author":"Morris","year":"2024","journal-title":"Laryngoscope"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071760","article-title":"MHC class I downregulation in cancer: underlying mechanisms and potential targets for cancer immunotherapy","volume":"12","author":"Cornel","year":"2020","journal-title":"Cancers"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3\u2013related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J Clin Invest"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1186\/s12885-023-11672-x","article-title":"Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE study","volume":"23","author":"H\u00e9l\u00e8ne","year":"2023","journal-title":"BMC Cancer"},{"key":"B66","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1359-6101(97)00009-9","article-title":"The interferon gamma (IFN-\u03b3) receptor: a paradigm for the multichain cytokine receptor","volume":"8","author":"Pestka","year":"1997","journal-title":"Cytokine Growth Factor Rev"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0053","article-title":"STAT1-induced HLA class I upregulation enhances immunogenicity and clinical response to anti-EGFR mAb cetuximab therapy in HNC patients","volume":"3","author":"Srivastava","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1186\/2051-1426-2-S3-P199","article-title":"IFN\u03b3-induced PD-L1 expression is JAK2 but not JAK1 dependent and its inhibition enhances NK-cetuximab mediated ADCC of HNSCC cells","volume":"2","author":"Concha-Benavente","year":"2014","journal-title":"J Immunother Cancer"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005158","article-title":"Efficacy of cetuximab plus PD-1 inhibitor differs by HPV status in head and neck squamous cell carcinoma: a systematic review and meta-analysis","volume":"10","author":"Zhang","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2023.106587","article-title":"Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): subgroup analysis by pattern of disease recurrence","volume":"147","author":"Harrington","year":"2023","journal-title":"Oral Oncol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.27348","article-title":"Lactate induces PD-L1 in HRASG12V-positive oropharyngeal squamous cell carcinoma","volume":"11","author":"Verma","year":"2020","journal-title":"Oncotarget"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.49020","article-title":"Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction","volume":"8","author":"Wang","year":"2019","journal-title":"eLife"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2018.01.007","article-title":"Soluble PD-L1 with PD-1-binding capacity exists in the plasma of patients with non-small cell lung cancer","volume":"196","author":"Takeuchi","year":"2018","journal-title":"Immunol Lett"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1384731","article-title":"Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer","volume":"15","author":"Ando","year":"2024","journal-title":"Front Pharmacol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-15-0305","article-title":"STAT1 activation is enhanced by cisplatin and variably affected by EGFR inhibition in HNSCC cells","volume":"14","author":"Schmitt","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20052494","article-title":"Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy","volume":"203","author":"Reits","year":"2006","journal-title":"J Exp Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2016.06.001","article-title":"Toxicities associated with head and neck cancer treatment and oncology-related clinical trials","volume":"40","author":"Villa","year":"2016","journal-title":"Curr Probl Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.3776","article-title":"Final results of the Sunbelt Melanoma Trial: a multi-institutional prospective randomized phase III study evaluating the role of adjuvant high-dose interferon alfa-2b and completion lymph node dissection for patients staged by sentinel lymph node biopsy","volume":"34","author":"McMasters","year":"2016","journal-title":"J Clin Oncol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb0152","article-title":"Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma","volume":"12","author":"Kalbasi","year":"2020","journal-title":"Sci Transl Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1710398","article-title":"ASTX660, an antagonist of cIAP1\/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer","volume":"9","author":"Ye","year":"2020","journal-title":"OncoImmunology"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-00272","article-title":"Xevinapant or placebo plus platinum-based chemoradiotherapy in unresected locally advanced squamous cell carcinoma of the head and neck (TrilynX): a randomized, phase III study","volume":"43","author":"Bourhis","year":"2025","journal-title":"J Clin Oncol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e923621","DOI":"10.12659\/MSM.923621","article-title":"Induction and regulation of the immunoproteasome subunit \u03b25i (PSMB8) in laryngeal and hypopharyngeal carcinoma cells","volume":"26","author":"Chen","year":"2020","journal-title":"Med Sci Monit"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-24-3239","article-title":"LSD1 inhibition induces MHC-I and dendritic cell activation to promote antitumor immunity in head and neck squamous cell carcinoma","volume":"86","author":"Chakraborty","year":"2026","journal-title":"Cancer Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41392-025-02266-z","article-title":"Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance","volume":"10","author":"Song","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004693","article-title":"Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells","volume":"10","author":"Maddineni","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002128","article-title":"Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells","volume":"9","author":"Lee","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2101169118","article-title":"Landscape of innate lymphoid cells in human head and neck cancer reveals divergent NK cell states in the tumor microenvironment","volume":"118","author":"Moreno-Nieves","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","article-title":"Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer","volume":"171","author":"Puram","year":"2017","journal-title":"Cell"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00531-9","article-title":"Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment","volume":"23","author":"Ruffin","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-011851","article-title":"Mapping immune activity in HPV-negative head and neck squamous cell carcinoma: a spatial multiomics analysis","volume":"13","author":"Zwing","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087206","article-title":"NLRC5-CIITA fusion protein as an effective inducer of MHC-I expression and antitumor immunity","volume":"24","author":"Santharam","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-021-00962-9","article-title":"Amplifying STING activation by cyclic dinucleotide\u2013manganese particles for local and systemic cancer metalloimmunotherapy","volume":"16","author":"Sun","year":"2021","journal-title":"Nat Nanotechnol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.canlet.2020.07.029","article-title":"Differential mutation spectrum and immune landscape in African Americans versus Whites: a possible determinant to health disparity in head and neck cancer","volume":"492","author":"Chaudhary","year":"2020","journal-title":"Cancer Lett"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1750775","article-title":"Integrated analysis of sex differences in human dendritic cell, monocyte, and natural killer cell subsets","volume":"17","author":"Yang","year":"2026","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2026.107929","article-title":"Sex-based immune differences influence tumor progression in head and neck squamous cell carcinoma","volume":"176","author":"Jagadeesha","year":"2026","journal-title":"Oral Oncol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"0003","DOI":"10.55092\/exrna20250003","article-title":"RNA cargo in motion: the exosomal connection to head and neck cancers","volume":"7","author":"Thasma Loganathan","year":"2025","journal-title":"ExRNA"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1907861\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:46:21Z","timestamp":1784695581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1907861\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":96,"alternative-id":["10.3389\/fonc.2026.1907861"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1907861","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"1907861"}}